180 Wealth Advisors’s Labcorp LH Stock Holding History

180 Wealth Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,483	Closed	-$578K	–	387
2022 Q1	$578K	Buy	2,483 +30	+1%	+$7.05K	0.13%	155
2021 Q4	$572K	Buy	2,453 +268	+12%	+$66.3K	0.13%	157
2021 Q3	$510K	Buy	2,185 +69	+3%	+$17.4K	0.11%	171
2021 Q2	$548K	Buy	2,116 +438	+26%	+$99.8K	0.13%	157
2021 Q1	$388K	Buy	+1,678	New	+$337K	0.1%	207

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

180 Wealth Advisors's LH Position: Q2 2022 in Review

180 Wealth Advisors sold out of Labcorp (LH) in Q2 2022, closing a stake of 2,483 shares — an estimated $578K sold.

180 Wealth Advisors first reported a position in LH in Q1 2021 and held it in 5 quarters. The position peaked at $578K in Q1 2022. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

180 Wealth Advisors reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
180 Wealth Advisors sold 2,483 Labcorp shares in Q2 2022, an estimated $578K.
180 Wealth Advisors first reported a position in Labcorp in Q1 2021 and held it in 5 quarters.
180 Wealth Advisors's Labcorp position peaked at $578K in Q1 2022.
966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on 180 Wealth Advisors's 13F filing for Q2 2022, filed 11 Jul 2022.